Alvotech (ALVO) Common Equity (2020 - 2026)
Alvotech's (ALVO) quarterly Common Equity came in at -$282.3 million in Q1 2026, up 31.61% YoY from -$214.5 million in Q1 2025, and up 0.76% on a QoQ basis from -$284.5 million in Q4 2025.
Alvotech (ALVO) Common Equity (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Common Equity data on file, last reported at -$282.3 million in Q1 2026.
- Quarterly Common Equity rose 31.61% year-over-year to -$282.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$282.3 million (up 31.61% YoY) and the FY2025 annual result came in at -$284.5 million, up 31.08% from the prior year.
- Common Equity rose to -$282.3 million in Q1 2026, from -$284.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of -$173.3 million in Q2 2025 to a low of -$932.5 million in Q4 2023.
- A 5-year average of -$465.3 million and a median of -$412.8 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity tumbled 316.2% — and 2025, when it surged 71.39%.
- Tracing ALVO's Common Equity over 5 years: stood at -$564.4 million in 2022, then tumbled by 65.21% to -$932.5 million in 2023, then jumped by 55.73% to -$412.8 million in 2024, then soared by 31.08% to -$284.5 million in 2025, then advanced by 0.76% to -$282.3 million in 2026.
- The last three Common Equity figures came in at -$282.3 million (Q1 2026), -$284.5 million (Q4 2025), and -$412.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | -282.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -282.31 Mn |
| Dec 31, 2025 | -284.49 Mn |
| Sep 30, 2025 | -412.77 Mn |
| Jun 30, 2025 | -173.33 Mn |
| Mar 31, 2025 | -412.77 Mn |
| Dec 31, 2024 | -412.77 Mn |
| Sep 30, 2024 | -343.71 Mn |
| Jun 30, 2024 | -605.92 Mn |
| Mar 31, 2024 | -658.83 Mn |
| Dec 31, 2023 | -932.49 Mn |
| Jun 30, 2023 | -478.54 Mn |
| Mar 31, 2023 | -655.77 Mn |
| Dec 31, 2022 | -564.42 Mn |
| Jun 30, 2022 | -296.22 Mn |
| Dec 31, 2021 | -135.61 Mn |
| Dec 31, 2020 | -867.24 Mn |